Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that have
mutations associated with increased transmission and antibody escape have arisen over the …

SARS-CoV-2 has caused a global pandemic that has infected more than 250 million people
worldwide. Although several vaccine candidates have received emergency use …

Background With the continuous emergence of new SARS-CoV-2 variants that feature
increased transmission and immune escape, there is an urgent demand for a better vaccine …

Boosting with updated COVID-19 mRNA vaccines | Nature Medicine Skip to main content
Thank you for visiting nature.com. You are using a browser version with limited support for …

With the relatively serious global epidemic outbreak of SARS-CoV-2 infection, public
concerns focus on not only clinical therapeutic measures and public quarantine for this …

A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) is urgently needed to tackle the COVID-19 global pandemic. Here, we describe the …

More than two years after the emergence of SARS-CoV-2, 33 COVID-19 vaccines, based on
different platforms, have been approved in 197 countries. Novel variants that are less …

The number and variability of the neutralizing epitopes targeted by polyclonal antibodies in
SARS-CoV-2 convalescent and vaccinated individuals are key determinants of …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
in the Omicron lineage has resulted in diminished Coronavirus Disease 2019 (COVID-19) …

The 2019 novel coronavirus (SARS-CoV-2) outbreak is a major challenge for public health.
SARS-CoV-2 infection in human has a broad clinical spectrum ranging from mild to severe …